(Fund7’s Portfolio)

A blood-testing platform engineered to bridge the gap from early detection to personalized cancer treatment selection.

They have developed a unique platform that captures cells in a majority of patients, and preserves the cells for downstream analysis that unlocking key data to inform clinical decision-making, as well as guides drug development